BridgeBio Pharma Inc Working Capital to Net Assets Ratio
BridgeBio Pharma Inc working capital to net assets ratio. BridgeBio Pharma Inc (BBIO) has a Working Capital to Net Assets ratio of -8.1% as of June 2026. Working capital of $202.49 Million (current assets of $1.09 Billion minus current liabilities of $890.65 Million) is measured against net assets of $-2.51 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check BridgeBio Pharma Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BridgeBio Pharma Inc (2017–2025)
Working capital to net assets ratio of BridgeBio Pharma Inc from 2017 to 2025. This chart shows how BridgeBio Pharma Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at -8.1%, reflecting working capital of $202.49 Million against net assets of $-2.51 Billion USD. See defensive interval ratio of BridgeBio Pharma Inc to measure how many days the company can operate on defensive assets alone.
BridgeBio Pharma Inc Working Capital to Net Assets Ratio by Year (2017–2025)
BridgeBio Pharma Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for BridgeBio Pharma Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BridgeBio Pharma Inc asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -22.4% | $465.71 Million | $-2.08 Billion | $753.68 Million | $287.97 Million | ▲ +16.4 pp |
| 2024 | -38.9% | $566.29 Million | $-1.46 Billion | $720.69 Million | $154.40 Million | ▼ -14.0 pp |
| 2023 | -24.9% | $333.75 Million | $-1.34 Billion | $477.59 Million | $143.84 Million | ▲ +9.5 pp |
| 2022 | -34.3% | $427.43 Million | $-1.24 Billion | $548.85 Million | $121.43 Million | ▲ +52.8 pp |
| 2021 | -87.1% | $753.79 Million | $-865.58 Million | $888.86 Million | $135.07 Million | ▼ -594.3 pp |
| 2020 | 507.2% | $547.18 Million | $107.89 Million | $642.82 Million | $95.65 Million | ▲ +400.4 pp |
| 2019 | 106.8% | $508.24 Million | $475.98 Million | $568.62 Million | $60.38 Million | ▲ +513.3 pp |
| 2018 | -406.5% | $412.65 Million | $-101.50 Million | $445.22 Million | $32.58 Million | ▼ -244.6 pp |
| 2017 | -162.0% | $88.58 Million | $-54.69 Million | $97.13 Million | $8.55 Million | — |